ABNORMAL PLACENTATION IN PREGNANT WOMEN WITH A SCAR ON THE UTERUS

Authors

DOI:

https://doi.org/10.11603/24116-4944.2021.1.12355

Keywords:

uterine scar, placentation, diagnosis, prognosis

Abstract

The aim of the study – to assess the frequency of abnormal placentation in pregnant women with a scar on the uterus.

Materials and Methods. The study was performed on the basis of the Odesa Regional Perinatal Center during 2016–2020. 435 women with a scar on the uterus were examined, including 118 (27.1 %) – with two or more scars. The average age of the patients was (33.3–1.2) years. The frequency of detection of placental abnormalities at the prenatal stage was analyzed. All patients during the 20-week pregnancy period underwent a transvaginal ultrasound examination using an Accuvix V20 Prestige expert-class scanner (Samsung Medison, Republic of Korea). Additionally, a Doppler study of blood flow through the uterine arteries was performed. Statistical analysis was performed using Statistica 13.0 software (TIBCO, USA).

Results and Discussion. In all examined pregnant women more than 2 years passed since the operation. Scar after conservative myomectomy was in 109 (25.1 %) women. The average term after CME was (2.7±0.2) years. Fundamental (28 or 25.7 %)  and corporal (73 or 66.9 %) incisions were most often registered. Anomalies of placental attachment were a frequent pheno­menon – in 70.3 %, with a low location of the placenta in the structure of the lesion – 163 cases or 53.3 %. Placenta accrete was registered in 131 or 42.8 %. The cases of placenta increta (2.6 %) and placenta previa (1.3 %) were casuistic. When assessing the frequency of complications in women with a scar on the uterus, it was found that in the first trimester of pregnancy the threat of abortion occurred in 20.4 % of pregnant women, early preeclampsia – in 50.3 %, anemia in pregnant women – in 64.1 %. Fetal growth retardation was registered in 69.6 % of pregnant women. In the third trimester, manifestations of placental dysfunction were registered in 72.1 %, preeclampsia – in 66.8 %, anemia of pregnant women – in 73.6 %. According to the literature, the prevalence of similar complications in women without scarring is three times lower. 103 (25.9 %) women underwent operative delivery, the rest gave birth per via naturales.

The most common cause of scarring on the uterus is СS (74.9 %). Scar after conservative myomectomy (CME) was in 109 (25.1 %) women. The average term after CME was (2.7±0.2) years. In contrast to women after CS, in whom the incision was always localized in the lower segment of the uterus, in patients with a scar on the uterus after CME, its location corresponded to the primary location of the removed myoma. Fundamental (28 or 25.7 %) and corporal (73 or 66.9 %) incisions were most often registered. Anomalies of placental attachment were a frequent phenomenon in 70.3 % of women, with a low location of the placenta in the structure of the lesion – 163 (53.3 %). Placenta accrete was registered in 42.8 % of pregnant women, placenta increta in 2.6 % and placenta previa in 1.3 %.

Author Biography

D. M. Zhelezov, Odesa National Medical University

Candidate of Medical Sciences, Assistant Professor of Obstetrics and Gynecology, Odesa National Medical University

References

Cali, G., Timor-Tritsch, I.E., Palacios-Jaraquemada, J., Monteaugudo, A., Buca, D., Forlani, F., …, & D'Antonio, F. (2018). Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet. Gynecol., 51 (2), 169-175. DOI: 10.1002/uog.17568.

Chen, D., Xu, J., Ye, P., Li, M., Duan, X., Zhao, F., …, & Peng, B. (2020). Risk scoring system with MRI for intraoperative massive hemorrhage in placenta previa and accreta. J. Magn. Reson Imaging., 51 (3), 947-958. DOI: 10.1002/jmri.26922.

Gonzalez, N., & Tulandi, T. (2017). Cesarean scar pregnancy: a systematic review. J. Minim. Invasive Gynecol., 24 (5), 731-738. DOI: 10.1016/j.jmig.2017.02.020.

Jauniaux, E., & Burton, G.J. (2018). Pathophysiology of placenta accreta spectrum disorders: a review of current findings. Clin. Obstet. Gynecol., 61 (4), 743-754. DOI: 10.1097/GRF.0000000000000392.

Jauniaux, E., Collins, S., & Burton, G.J. (2018). Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am. J. Obstet. Gynecol., 218 (1), 75-87. DOI: 10.1016/j.ajog.2017.05.067.

Lum, M., & Tsiouris, A. (2020). MRI safety considerations during pregnancy. J. Clin. Imaging., 62, 69-75. DOI: 10.1016/j.clinimag.2020.02.007.

Miyakoshi, K., Otani, T., Kondoh, E., Makino, S., Tanaka, M., & Takeda, S. (2018). Retrospective multicenter study of leaving the placenta in situ for patients with placenta previa on a cesarean scar. Int. J. Gynaecol. Obstet., 140 (3), 345-351. DOI: 10.1002/ijgo.12397.

Zhelezov, D. (2019). Periconceptional remodeling of myometrium after surgical interventions on the uterus: ultrasonographic aspects. Georgian Med News., 297, 31-34.

Fatusic, J., Hudic, I., Zildzic-Moralic, A., & Hadziefendic, B. (2019). Cesarean scar pregnancy complicated with placenta percreta. Med. Arch., 73 (1), 58-60. DOI: 10.5455/medarh.2019.73.58-60.

Shainker, S.A., Coleman, B., Timor-Tritsch, I.E., Bhide, A., Bromley, B., Cahill, A.G., …, & Abuhamad, A. (2021). Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. Am. J. Obstet. Gynecol., 224 (1), B2-B14. DOI: 10.1016/j.ajog.2020.09.001.

Silver, R.M., & Barbour, K.D. (2015). Placenta accreta spectrum: accreta, increta, and percreta. Obstet. Gynecol. Clin. North Am., 42 (2), 381-402. DOI: 10.1016/j.ogc.2015.01.014.

Cahill, A.G., Beigi, R., Heine, R.P., Silver, R.M., & Wax, J.R. (2018). Placenta accreta spectrum. Am. J. Obstet. Gynecol., 219 (6), B2-B16. DOI: 10.1056/NEJMcp1709324.

Bartels, H.C., Postle, J.D., Downey, P., & Brennan, D.J. (2018). Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis. Markers., 2018, 1507674. DOI: 10.1155/2018/1507674.

Dashraath, P., & Lin, H.Z. (2016). Placenta increta. N. Engl. J. Med., 375 (14), 1382. DOI: 10.1056/NEJMicm1513423.

Kingdom, J.C., Hobson, S.R., Murji, A., Allen, L., Windrim, R.C., Lockhart, E., …, & Fox, K.A. (2020). Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020. Am. J. Obstet. Gynecol., 223 (3), 322-329. DOI: 10.1016/j.ajog.2020.01.044.

Di Mascio, D., Calì, G., & D'antonio, F. (2019). Updates on the management of placenta accreta spectrum. Minerva Ginecol., 71 (2), 113-120. DOI: 10.23736/S0026-4784.18.04333-2.

Berkley, E.M., & Abuhamad, A. (2018). Imaging of placenta accreta spectrum. Clin. Obstet. Gynecol., 61 (4), 755-765. DOI: 10.1097/GRF.0000000000000407.

Kilcoyne, A., Shenoy-Bhangle, A.S., Roberts, D.J., Sisodia, R.C., Gervais, D.A., & Lee, S.I. (2017). MRI of placenta accreta, placenta increta, and placenta percreta: pearls and pitfalls. AJR. Am. J. Roentgenol., 208 (1), 214-221. DOI: 10.2214/AJR.16.16281.

Jauniaux, E., Hussein, A.M., Fox, K.A., & Collins, S.L. (2019). New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders. Best Pract. Res. Clin. Obstet. Gynaecol., 61, 75-88. DOI: 10.1016/j.bpobgyn.2019.04.006.

Thiravit, S., Lapatikarn, S., Muangsomboon, K., Suvannarerg, V., Thiravit, P., & Korpraphong, P. (2017). MRI of placenta percreta: differentiation from other entities of placental adhesive disorder. Radiol. Med., 122 (1), 61-68. DOI: 10.1007/s11547-016-0689-3.

Published

2021-09-09

How to Cite

Zhelezov, D. M. (2021). ABNORMAL PLACENTATION IN PREGNANT WOMEN WITH A SCAR ON THE UTERUS. Actual Problems of Pediatrics, Obstetrics and Gynecology, (1), 55–59. https://doi.org/10.11603/24116-4944.2021.1.12355

Issue

Section

OBSTETRICS AND GYNECOLOGY